Epstein Secrets

ees. The New York Times <https://www.nytimes.com/2020/11/12/business/pfizer-covid-vaccine-coronavirus.html> (11/12, Gelles, Robins, 18.61M) reports Pfizer, the US government, and "the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the h

ters <https://www.reuters.corn/article/us-health-coronavirus-fatality/covid-19-fatality-rate-down-30-since- april-study-finds-idUSICBN27S39D> (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

al-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug companie

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

an Orlando Hernandez and Bolivia's then-interim President Jeanine Anez. All have recovered." Mexico's Vaccination Program Stalls Due To Delays from Pfizer. The Los Angeles Times (1/24, Linthicum, 3.37M) reports that hospitals in many states in Mexico "are near EFTA00148194 capacity, ventilators and

break from Trump's discursive approach to the pandemic as cases continue to climb nationwide." USA Today (1/24, Rivera, 12.7M) and Politico (1/24, Beasley, 6.73M) also report. US Passes 25M Confirmed Cases; Epidemiologist Pegs Total At More Than 105M. The AP (1/24) says "the new milestone" of 25 milli

istribution Requires Cooperation Between Governments, Drug Makers, Suppliers, Employees. The New York Times (11/12, Gelles, Robins, 18.61M) reports Pfizer, the US government, and "the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the h

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

istribution Requires Cooperation Between Governments, Drug Makers, Suppliers, Employees. The New York Times (11/12, Gelles, Robins, 18.61M) reports Pfizer, the US government, and "the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the h

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-